Clearside Biomedical (NASDAQ:CLSD) appointed Rick McElheny as VP of business development, with responsibility for existing collaborations and establishing new collaborations for Clearside’s product candidates and programs.
Mr. McElheny has expertise in business development, finance, market research, strategic planning, and supply chain management within the specialty pharmaceutical industry. Most recently, he served as SVP of corporate development at Sarvint Technologies.
“I am delighted to have someone with Rick’s caliber join the Clearside team to build out future collaborations with innovative companies as we seek to develop transformative, elegant, precise solutions to restore and preserve vision,” Daniel White, president and CEO of Clearside, said in a statement.
“Rick is an accomplished professional in developing partnerships that enhance shareholder value and I am confident he will do the same at Clearside,” he added.